A prospective, hospital-based cohort enrolled patients with surgically confirmed necrotizing fasciitis at Mubende, Hoima, and Fort Portal Regional Referral Hospitals between April and August 2025. The study team followed participants until discharge or death and obtained wound swabs and tissue samples for bacterial culture and antimicrobial susceptibility testing. The authors reported 64 enrolled patients; 56.3% were male and the median age group listed in the abstract was 13–18 years. Modified Poisson regression was used to identify independent predictors of mortality, according to the source abstract.
The investigators framed the work around a persistent clinical problem in low-resource settings: high mortality from rapidly progressive soft-tissue infection and limited microbiology data to guide empiric therapy.
Bacterial recovery favored polymicrobial disease. The cohort showed Type I polymicrobial infections in 60.9% of cases, while Type II monomicrobial infections accounted for 29.7%, per the abstract. The most commonly isolated taxa were Streptococcus spp. (24.6%) and Staphylococcus spp. (20.2%). Gram-negative Enterobacterales were also present: Escherichia coli (18.4%) and Klebsiella spp. (14.9%). Anaerobic isolates, including Bacteroides and Clostridium spp., were reported as part of the microbiologic mix.
Susceptibility patterns reported in the abstract varied by organism. Streptococcus spp. retained high susceptibility to ceftriaxone (92.9%) and clindamycin (96.4%). By contrast, Staphylococcus spp. exhibited high resistance to Ampicillin (73.9%) while maintaining substantial sensitivity to vancomycin (87.0%). The Enterobacterales isolates demonstrated multi-drug resistance phenotypes but, according to the abstract, remained largely susceptible to carbapenems (imipenem/meropenem, reported 95–100%) and ciprofloxacin (> 90%). Anaerobes were reported to show high sensitivity to metronidazole (75–100%) in the tested isolates.
The abstract does not include isolate-level susceptibility tables, minimum inhibitory concentration distributions, or the full panel of antibiotics tested. The study team did not report those granular data in the abstract.
The authors applied modified Poisson regression to identify independent predictors of mortality. Data indicated that diabetes mellitus, prior use of herbal medicine, undernutrition, and anaerobic bacterial infection were independently associated with increased risk of death (all reported p < 0.05). The cohort’s age distribution, comorbidity profile beyond diabetes, timing of presentation, and surgical management details were summarized in the full text but are not delineated in the abstract itself.
The source abstract does not provide adjusted risk ratios, confidence intervals, or model covariates; those quantitative model outputs are not reported in the abstract and therefore cannot be restated here.
On the basis of organism prevalence and susceptibility patterns reported, the authors recommended that empiric regimens in low-resource environments include anaerobic coverage. The abstract specifically names metronidazole or clindamycin as viable options to broaden coverage for anaerobes. The antimicrobial results further suggest that empiric coverage for streptococci and staphylococci should consider the observed resistance to Ampicillin among Staphylococcus spp. and the retained susceptibility of streptococci to ceftriaxone and clindamycin. For suspected Gram-negative involvement, the reported carbapenem and ciprofloxacin susceptibilities may inform escalation where available.
The source did not report specific empiric dosing regimens, duration of therapy, or local antibiotic stewardship protocols in the abstract.
Ethical oversight was obtained: the research followed the Declaration of Helsinki principles and received approval from the Kampala International University Research and Ethics Committee (Approval number: KIU-2024–731), and enrolled patients provided written informed consent, according to the conflict of interest statement. The authors declared no competing interests.
Key gaps remain in the abstracted record. The source did not report isolate-level susceptibility tables, exact model coefficients or confidence intervals for the predictors of mortality, detailed surgical timelines, or specific antimicrobial dosing and duration. The abstract also does not provide long-term outcomes beyond hospital discharge. Those details may appear in the full text but are not present in the abstract, and therefore were not available for this summary.
Limitations explicitly documented in the abstract are limited; the source did not report study limitations, next regulatory milestones, or protocol amendments in the abstract. Specific unanswered clinical questions documented in the source are the need for empiric anaerobic coverage in low-resource settings and the contribution of traditional/herbal treatments and malnutrition to worse outcomes; the abstract stops short of reporting broader programmatic steps or planned follow-up studies.